A prolonged severe intoxication after ingestion of phenytoin and phenobarbital.

trol subjects,20 we have seen a clear relationship between pubertal development (Tanner stage) and increased daytime sleepiness in the absence of any changes in total nighttime sleep. Multiple sleep latency test scores showed a significant increase in daytime sleepiness at Tanner stages 3 and 4. From these data we have hypothesized that this period of maturation might be a particularly vulnerable stage in the development of narcolepsy. In the present case the signs and symptoms of narcolepsy were first seen at Tanner stage 4, supporting this hypothesis. The findings in this case suggest the possibility of an additive effect wherein a preexisting tendency toward daytime sleepiness and the pubertal augmentation of sleepiness lead to an unequivocally pathological level of sleepiness.

[1]  D. G. Fraser,et al.  Phenytoin toxicity and blood levels after a large oral dose. , 1980, American journal of hospital pharmacy.

[2]  S. Garella,et al.  Hemoperfusion to treat intoxications. , 1979, Annals of internal medicine.

[3]  J. Wilson,et al.  Prolonged toxicity following acute phenytoin overdose in a child. , 1979, The Journal of pediatrics.

[4]  A. Richens Clinical Pharmacokinetics of Phenytoin , 1979, Clinical pharmacokinetics.

[5]  L. Marton,et al.  A Simultaneous High-Performance Liquid Chromatographic Analysis of the Most Common Anticonvulsants and Their Metabolites in the Serum , 1978 .

[6]  J. McKeon,et al.  Phenytoin overdose. Kinetics. , 1978, Western Journal of Medicine.

[7]  J. Spire,et al.  Hemodialysis of phenytoin in a uremic patient , 1975, Clinical pharmacology and therapeutics.

[8]  M. Wall,et al.  A complex pattern of disposition of phenytoin in severe intoxication , 1975, Clinical pharmacology and therapeutics.

[9]  H. Kutt Interactions of Antiepileptic Drugs , 1975, Epilepsia.

[10]  H. Meinardi,et al.  Absorption and Distribution of Antiepileptic Drugs , 1975, Epilepsia.

[11]  G. Plaa Acute Toxicity of Antiepileptic Drugs , 1975, Epilepsia.

[12]  R. Beam Broad-spectrum simultaneous GLC assay of nonderivatized antiepileptic drugs. , 1974, The American journal of medical technology.

[13]  Diphenylhydantoin side effects and serum albumin levels , 1973, Clinical pharmacology and therapeutics.

[14]  J. M. Shaw,et al.  Pharmacokinetic study of a patient with diphenylhydantoin toxicity , 1973, Clinical pharmacology and therapeutics.

[15]  H. Booker,et al.  Serum Concentrations of Free Diphenylhydantoin and their Relationship To Clinical Intoxication , 1973, Epilepsia.

[16]  H. Kutt,et al.  BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN * , 1971, Annals of the New York Academy of Sciences.

[17]  K. Arnold,et al.  The rate of decline of diphenylhydantoin in human plasma , 1970, Clinical pharmacology and therapeutics.

[18]  D. Sherrard,et al.  Acute diphenylhydantoin intoxication. , 1968, American journal of diseases of children.

[19]  D. Wingate,et al.  Acute diphenylhydantoin and primidone poisoning treated by peritoneal dialysis. , 1968, Journal of neurology, neurosurgery, and psychiatry.

[20]  Harold L. Williams,et al.  Some Effects of Sleep Loss on Memory , 1966, Perceptual and motor skills.

[21]  H. Kutt,et al.  DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY. , 1964, Archives of neurology.

[22]  F. Mcdowell,et al.  Insufficient parahydroxylation as a cause of diphenylhydantoin toxicity , 1964, Neurology.

[23]  J. Sours NARCOLEPSY AND OTHER DISTURBANCES IN THE SLEEP‐WAKING RHYTHM: A STUDY OF 115 CASES WITH REVIEW OF THE LITERATURE , 1963, The Journal of nervous and mental disease.

[24]  P. Doolan,et al.  Acute Dilantin poisoning , 1961, Neurology.

[25]  D. Daly,et al.  A family with narcolepsy. , 1959, Proceedings of the staff meetings. Mayo Clinic.

[26]  G. Schreiner The role of hemodialysis (artificial kidney) in acute poisoning. , 1958, A.M.A. archives of internal medicine.